Emerging Trends in Hematology – ASH 2023 Highlights
In December 2023, Medpace classic and malignant hematology experts attended the 65th American Hematology Society (ASH) conference in San Diego, CA. Learn more from Blythe…
[On-Demand Webinar] Liquid Biopsy in Oncology: Opportunities and Challenges
Join featured speakers from Medpace on September 8th, as they provide an overview of the current methodologies involved in liquid biopsies and their application for…
Blythe Thomson, MD, Rejoins Medpace Bringing New Experiences and Insights from a Sponsor’s Perspective
Medpace is pleased to announce that Dr. Blythe Thomson has rejoined Medpace’s Hematology and Oncology medical leadership team after spending several years holding a variety…
Infectious Diseases in the Immunocompromised Host
An in-depth look at infectious diseases including hematologic malignancies in immunocompromised patients and the unique challenges for clinical development.
Medpace’s Focus on Hematology and Oncology Aligns with Innovative Biotechs
Europe is a vital contributor to a new wave of technology that is changing the face of treatments and clinical development